ReviewFrontiers in pharmacology2023

Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis.

Dan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.